CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

Adenosine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 20 USDMF, 4 CEP/COS, 1 EU WC, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

57 FDF Dossiers, 33 FDA Orange Book, 5 Europe, 4 Canada, 2 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

10 Evonik, 7 Rochem International Inc, 14 SPI Pharma, 18 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 8 Gangwal Healthcare, 2 Kewpie Corporation, 24 Nanjing Well Pharmaceutical, 4 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 1 Bioplus Life Sciences, 2 BioSpectra, 2 Clariant, 16 Corel Pharma Chem, 4 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 4 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 18 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 6 Lubrizol Life Science Health, 12 Microlex e.U, 4 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Novo Excipients, 5 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 28 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 3 The Dow Chemical Company, 1 TopChem Pharmaceuticals, 2 Valens Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Topical, 65 Solubilizers, 54 Thickeners and Stabilizers, 50 Coating Systems & Additives, 40 Fillers, Diluents & Binders, 39 Emulsifying Agents, 35 Parenteral, 27 Taste Masking, 26 Film Formers & Plasticizers, 24 Surfactant & Foaming Agents, 21 Controlled & Modified Release, 20 Direct Compression, 17 Co-Processed Excipients, 12 Rheology Modifiers, 12 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 10 Granulation, 9 API Stability Enhancers, 9 Empty Capsules, 8 Disintegrants & Superdisintegrants, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 Finished Drug Prices, 3 Annual Reports

MARKET PLACE

19 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/11/2024	Actylis	U.S.A	PHARMA-WALDHOF GMBH	7728	ADENOSINE	1988-10-25	Active	II	Complete	2013-06-08	2013-05-30
28/11/2024	Actylis	U.S.A	PHARMA-WALDHOF GMBH	8713	N6-(2-ISOPENTENYL)-ADENOSINE	1990-08-17	Inactive	II	N/A

Adenosine

Adenosine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

20 USDMF

4 CEP/COS

1 EU WC

4 NDC API

7 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

57 FDF Dossiers

33 FDA Orange Book

5 Europe

4 Canada

2 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

10 Evonik

7 Rochem International Inc

14 SPI Pharma

18 DKSH

1 Pharm-RX Chemical

4 Faran Shimi Pharmaceutical

8 Gangwal Healthcare

2 Kewpie Corporation

24 Nanjing Well Pharmaceutical

4 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

11 Actylis

2 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

20 BASF

1 Bioplus Life Sciences

2 BioSpectra

2 Clariant

16 Corel Pharma Chem

4 Finar

16 Gangwal Chemicals

2 Hayashibara

4 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

18 Kerry

4 Kima Chemical

6 Lonza Capsugel

6 Lubrizol Life Science Health

12 Microlex e.U

4 Nanjing Bold Chemical

2 Nippon Fine Chemical

1 Novo Excipients

5 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

31 Roquette

28 Seppic

3 Shandong Focus Biotechnology Co., Ltd

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

3 The Dow Chemical Company

1 TopChem Pharmaceuticals

2 Valens Pharmachem

1 Vertellus

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Topical

65 Solubilizers

54 Thickeners and Stabilizers

50 Coating Systems & Additives

40 Fillers, Diluents & Binders

39 Emulsifying Agents

INJECTABLE;INJECTION - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons